Skip to content

Safety and efficacy assessment of Product on skin

To evaluate the in-vivo efficacy and safety of a skin care regime in terms of anti-aging effects i.e., reduction in fine lines and wrinkles, reduction in density of dark spots (age spots), improvement in skin moisturization, improvement in skin brightening and improvement in skin firmness on healthy female subjects.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050222
Enrollment
36
Registered
2023-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: HKVitals Collagen Face Cleanser:Product A: This is the first product of test regime. Take 0.5gm quantity of test product and massage all over the face. Rinse with water and pat dry. App

Sponsors

BRIGHT LIFECARE PVT. LTD.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian female subjects. 2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) 3.Between 35 and 55 years of age. 4.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)

Exclusion criteria

Exclusion criteria: 1.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2.Having refused to give her/his assent by signing the consent form 3.Taking part in another study liable to interfere with this study 4.Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5.Being asthmatic. 6. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex 7.Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 8.Having cutaneous hypersensitivity. 9.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 10.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 11.Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit. 12.Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted) 13.Refusing to follow the restrictions below during the study: - Do not take part in any family planning activities leading to pregnancy and breastfeeding - Do not take part in another study liable to interfere with this study - Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). - Do not change his/her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit. - Do not practice water activities (swimming pool, sauna, hammam, balneotherapy) - During the study: Do not use other cosmetic products than the tested products to the studied areas. Do not use hair oil - The day of the measurements : No other cosmetic products must be used (only face cleaned with water is accepted) 14.Having started, changed or stopped a Hormone Replacement Therapy in the past 6 months. 15.Having started, changed or stopped her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months. 16. Having taken a Dehydroepiandrosterone based treatment in the previous 6 months. 17.Having applied products with an anti-wrinkle action particularly firming products (Retinoic acid, retinol, retinaldehyde, Alpha Hydroxy Acid….) in the 2 weeks preceding the start of the study. 18.Having made injections of anti-wrinkle products (collagen, hyaluronic acid, botulinic toxin…) in the previous 12 months. 19. Having undergone techniques with aesthetic aim (chemical peel, mechanical dermabrasion, laser, pulsed flash lamp …) in the previous year. 20. Having undergone surgery of the skin-muscular slackening on the face (lifting) in the previous 5 years. 21.Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene…) 22. Having applied products with a depigmenting action (hydroquinone or derivates…) in the 4 weeks preceding the start of

Design outcomes

Primary

MeasureTime frame
Reduction in fine lines and wrinkles, reduction in density of dark spots (age spots), improvement in skin moisturization, improvement in skin brightening and improvement in skin firmnessTimepoint: Baseline, 28 days, 56 days & 84 days

Secondary

MeasureTime frame
NilTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026